Skip to content
Donate
Membership
Contact
  • About

    About

    The peak professional body for childhood cancer across Australia and New Zealand.

    Learn More

    Menu

    • About ANZCHOG
    • Board of Directors
    • Our People
    • Our Network
    • Supporters & Partners
    • Position Statements & Guidelines
  • Clinical Trials
    Total Trials
    60
    Open Trials
    26
    Preparing to Open
    3
    Temp. Closed
    3
    Closed
    21
    Complete
    7

    Menu

    • Our Trials
    • Children's Clinical Cancer Clinical Trials Repository
    • Childhood Cancer
  • Resource SPACE
    Document/ PDF

    Supporting parents making clinical trial decisions for their child

    Behavioural Sciences Unit – Delta Study
    Document/ PDF

    Should my child participate in a clinical trial

    Center for Information and Study on Clinical Research Participation (CISCRP)

    Menu

    • Visit SPACE
    • Videos
    • Documents
    • Podcasts
  • Major Projects
    • July 2, 2025

    Getting to know CoACT in Brain Cancer Awareness Month

    • childhoodcancer, clinical trials, Paediatric Brain Cancer
    • February 6, 2025

    Australian Government invests $14 million in ANZCHOG-led childhood brain cancer initiative

    • childhoodcancer, clinical trials, Paediatric Brain Cancer

    Menu

    • CoACT
    • Equitable Pathways
    • CIRCCA
    • Optimal Care Pathways
  • Annual Scientific Meeting

     Innovate, Integrate, Inspire:   Elevating Supportive Care in Paediatric Haematology and Oncology  

    Learn More

    Menu

    • 2026 Newcastle
    • Program
    • Speakers
    • Accommodation
  • News & Events
    • Featured, PaedNeoVax, Trial Update
    • November 5, 2026

    PaedNeoVax Clinical Trial Opens to Target Aggressive Childhood Brain Tumours

    Menu

    • Latest News
    • Upcoming Events

    8–11 September 2027

    SIOP 2027

  • About Us
    • ANZCHOG
    • Board of Directors
    • Our People
    • Our Network
    • Collaborators, Supporters & Partners
  • Clinical Trials
    • Clinical Trials
    • ANZCHOG Children’s Cancer Clinical Trials Repository
    • Childhood Cancer
  • Major Projects
    • CIRCAA
    • CoACT
    • Equitable Pathways
    • Optimal Care Pathways
  • Resource Space
  • Membership
  • Annual Scientific Meeting
Membership
Donate
Contact
OpenPhase 1

INTER-EWING-1 (RG_21-151)

International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma - Trial 1

View on registry →ANZCTR: https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12624000532505 · Registry IDs: ISRCTN17938906

INTER-EWING-1 is a large international trial for children and young adults newly diagnosed with Ewing Sarcoma, a rare bone and soft tissue cancer. The study aims to find a more effective treatment by testing three specific changes: adding a new targeted drug called regorafenib to chemotherapy, refining radiation therapy doses, and testing if extra chemotherapy at the end of treatment prevents the cancer from coming back. By evaluating these different approaches, researchers hope to increase survival rates and improve the long term health of young survivors by finding the most effective balance of treatments.

INTER-EWING-1 is an international, multi arm, randomised Phase III trial for patients with newly diagnosed Ewing Sarcoma. The study evaluates therapeutic intensifications to improve event free survival (EFS) beyond the current standard of care. It investigates the efficacy of adding regorafenib to chemotherapy, the optimisation of radiotherapy dose and volume, and the impact of maintenance chemotherapy following standard treatment. By stratifying patients based on risk and response, the trial seeks to establish new global care standards while minimising long term toxicities.

Site Status
Queensland Children's Hospital (QLD) Open
John Hunter Children's Hospital (NSW) Open
Sydney Children's Hospital (NSW) Open
Monash Children's Hospital (VIC) Open
Royal Children's Hospital (VIC) Open
Perth Children's Hospital (WA) Open
Children's Hospital at Westmead (NSW) Open
Starship Children's Hospital (NZ) Open
Christchurch Hospital (NZ) Open
Chris O'Brien Lifehouse Open
Peter MacCallum Cancer Centre Open
Princess Alexandra Hospital Open
Royal Adelaide Hospital Open
Women's and Children's Hospital (SA) Preparing to Open
Preparing to openOpenClosedComplete
Adult SitesChris O'Brien LifehousePeter MacCallum Cancer CentrePrincess Alexandra HospitalRoyal Adelaide HospitalThese sites are not monitored. Status may vary.
Diagnosis StageNewly Diagnosed
National SponsorANZCHOG
Open Date21/06/2024
ConditionsEwing Sarcoma
Patient Range> 2 years +
05099+
Disease TypeSoft Tissue and Bone Tumours (Sarcoma)
Study TypeTreatment
International SponsorUniversity of Birmingham

Funders

ANZCHOG acknowledges the valuable support of INTER-EWING-1 (RG_21-151) by:

The Australian Organisation For Young People Living With Cancer Charity (Canteen)
The Kids Cancer Project
Australian Government's Medical Research Future Fund
Australia and New Zealand Sarcoma Association

Related news

#newsREGO-EWING-1 (RG_21-151) trial opens in third Australian stateThe ANZCHOG sponsored, REGO-EWING trial has recently opened at Monash Children’s Hospital, having opened earlier this year at Perth Children’s Hospital and…April 1, 2024→

Media & Publication Highlights

Last updated 11 November 2026

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

Subscribe to our Newsletter

    • Terms Of Use
    • Privacy Policy
    • Terms Of Use
    • Privacy Policy
    • Resource Hub
    • Childhood Cancer
    • What We Do
    • Resource Hub
    • Childhood Cancer
    • What We Do
    • Our Trials
    • Our Network
    • Position Statements & Guidelines
    • Our Trials
    • Our Network
    • Position Statements & Guidelines

    Email
    info@anzchog.org

    Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

    Copyright © 2026 ANZCHOG - All Rights Reserved

    Linkedin-in